By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751


SEARCH JOBS


Industry
Biotechnology






Company News
Rumor: Sarepta Therapeutics (SRPT) Chairman Moves To Keep CEO Out Of FDA Meetings 7/30/2014 6:38:05 AM
Stop Squabbling, Mom Tells Troubled Sarepta Therapeutics (SRPT): "Just Get My Kid The Drug" 7/29/2014 6:44:56 AM
Sarepta Therapeutics (SRPT) Terminates Chief Science Officer As It Heads Toward Drug Approval 7/24/2014 7:53:04 AM
Latest Sarepta Therapeutics (SRPT) Phase 2 Data Shows Greater Decline in Walking Ability For Muscular Dystrophy Patients 7/10/2014 7:27:19 AM
Sarepta Therapeutics (SRPT) Quietly Buys Eisai Company, Ltd. (ESALY.PK)'s Vacant R&D Lab In Cambridge For $25 Million 7/7/2014 6:41:06 AM
Sarepta Therapeutics (SRPT) To Present Company Overview At The JMP Securities Healthcare Conference On June 24 6/19/2014 8:16:35 AM
Sarepta Therapeutics (SRPT) Opens New Global Headquarters In Cambridge, Mass. 6/2/2014 10:31:12 AM
Sarepta Therapeutics (SRPT) Announces Agreement For Acquisition Of Manufacturing Facility In Massachusetts 5/22/2014 9:46:28 AM
Boston CEO Conference To Feature Ceos Of Aegerion Pharmaceuticals, Inc. (AEGR), Alkermes plc (ALKS), Alnylam Pharmaceuticals (ALNY), Flex Pharma, Genzyme Corporation (GENZ), Infinity Pharmaceuticals Inc. (INFI), OvaScience (OVAS), Sarepta Therapeutics (SRPT), Tesaro, Inc. (TSRO), Verastem, Inc. (VSTM) And Others June 4th And 5th 5/20/2014 7:03:42 AM
Sarepta Therapeutics (SRPT) To Present Company Overview At The UBS Global Healthcare Conference On May 20 5/16/2014 6:55:45 AM
12345678910...
//-->